| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/07/2009 | US7514610 Plants and seeds of corn variety CV211902 |
| 04/07/2009 | US7514608 Garden bean cultivar H26106 |
| 04/07/2009 | US7514603 Soybean cultivar 6917445 |
| 04/07/2009 | US7514601 Soybean variety XB19E07 |
| 04/07/2009 | US7514599 Protein kinase stress-related proteins and methods of use in plants |
| 04/07/2009 | US7514598 Preparing plants with enhanced invertase inhibition for use in generating seeds with increased reserves; tissue engineering |
| 04/07/2009 | US7514597 Glycosyltransferase gene |
| 04/07/2009 | US7514596 Methods for simultaneous control of lignin content and composition, and cellulose content in plants |
| 04/07/2009 | US7514595 Targeted and regional cellular ablation in zebrafish |
| 04/07/2009 | US7514594 Somatic and/or germ cells comprising a nucleic acid with promoter capable of directing protein expression; use in treating, diagnosing and preventing osteoporosis |
| 04/07/2009 | US7514593 Animal model for chronic obstructive pulmonary disease and cystic fibrosis |
| 04/07/2009 | US7514592 transgenic rodents genetically engineered to knock out gene expression of active scavenger receptor class BI (SR-BI) and having apolipoprotein E activity or expression decreased to 2-5% of normal levels; models of cardiovascular disoders induced by feeding a lipid enriched diet |
| 04/07/2009 | US7514550 Sense and antisense regions; kits for gene silencing |
| 04/07/2009 | US7514547 Helicobacter felis vaccine |
| 04/07/2009 | US7514546 Antibodies |
| 04/07/2009 | US7514545 An isolated nucleotide sequence encoding a regulatory fusion protein consisting of modified ligand-binding domain of a human estrogen receptor and a transcription blocking domain comprising a mutated restriction enzyme capable of binding but not cleaving DNA |
| 04/07/2009 | US7514544 Expression vector comprising nucleotide sequences coding bacillus delta -endotoxin for use in transformation and generation of insect resistant corn |
| 04/07/2009 | US7514542 Collagen-like protein CLAC, precursor thereof and genes encoding the same |
| 04/07/2009 | US7514537 Chimeric immunoreceptor useful in treating human gliomas |
| 04/07/2009 | US7514536 interleukins produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; polypeptide has anti-hepatitis C activity |
| 04/07/2009 | US7514535 Chimeric immunogens |
| 04/07/2009 | US7514532 Insulin-like growth factor polypeptide; for treating solid tumors having cells expressing IGFBP-3 receptors |
| 04/07/2009 | US7514416 Suppressing growth of pancreatic tumors or cancer cells having a K-ras gene point mutation by administering directly to the tumor cells an adenoviral vector having a DNA sequence encoding human interferon alpha and linked to a promoter and an antisense K-ras expressing vector |
| 04/07/2009 | US7514415 Suppressing an immune response in rheumatoid arthritis by administering a pure or isolated oligodeoxynucleotide of up to 100 nucleotides in length along with an additional antiinflammatory agent, immunosuppressive agent or antiarthritis agent |
| 04/07/2009 | US7514414 Autoimmune disease; bactericides, viricides, fungicides, parasiticides |
| 04/07/2009 | US7514403 Process for the stabilization of proteins in an aqueous solution comprising cysteine in a concentration between 150 and 220mM |
| 04/07/2009 | US7514401 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease |
| 04/07/2009 | US7514398 Growth factor complex |
| 04/07/2009 | US7514397 Administering homologs of peptides corresponding to amino acid residues 638 to 673, and to amino acid residues 558 to 595, of the human immunodeficiency virus-1LAI transmembrane protein glycoprotein 41; inhibiting membrane fusion |
| 04/07/2009 | US7514258 regeneration of animal embryos by inserting a nucleus of a differentiated cell into an enucleated oocyte, then culturing the regenerated embryo and isolating the cells; production of transgenic animals; genetic engineering |
| 04/07/2009 | US7514254 having hydrolase enzyme activity, used for hydrolsis of an alpha-galactosyl saccharide contained in foodstuff such as soy bean products, thus reducing the capability of the foodstuff to cause flatulence during digestion |
| 04/07/2009 | US7514253 Expression vector comprising nucleotide sequences coding orotate-phosphoribosyl transferase (URA-5) for use reporter tool in heterologous gene transfer; bioreactors |
| 04/07/2009 | US7514252 Tumor/cancer therapy/drugs for infecting/killing cells with mutant virus; comprises deletion or inactivating mutation in both copies of gene, at least one copy is reintroduced under transcriptional control of cell-specific and/or tumor-specific promoter; capable of delivering transgene cytotoxic to tumor |
| 04/07/2009 | US7514251 For production of methylated catechols; plant cell propagation |
| 04/07/2009 | US7514242 Process for producing dipeptides |
| 04/07/2009 | US7514241 conducting nucleic acid sequence-based amplification or self sustained sequence replication on a sample using primers comprising a first and second nucleotide sequence, and a RNA polymerase promoter sequence, then detecting amplified nucleic acids, indicative of the presence of shiga-like toxin RNA |
| 04/07/2009 | US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders |
| 04/07/2009 | US7514238 Growth factor homolog zvegf4 |
| 04/07/2009 | US7514236 genetically modified microorganism of the family of Actinomycetales of the Rhodococcus genus blocked in 3-ketosteroid 9 alpha -hydroxylase activity; useful in the microbial degradation of steroids to accumulate certain steroid products |
| 04/07/2009 | US7514227 contacting an antibodies or fragments which binds to human mitochondrial adenylate kinase isozymes with biological sample from a subject and normal control subject, then detecting the immune complex formed as detection markers for diagnosing myocardial infarction |
| 04/07/2009 | US7514222 polypeptides or proteins consisting of a four helix bundle formed of two dimerized helix-loop-helix motifs |
| 04/07/2009 | US7514221 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1) |
| 04/07/2009 | US7514218 Processes for purifying and for detecting target double-stranded DNA sequences by triple helix interaction |
| 04/07/2009 | US7514216 Methods for generating hypermutable yeast |
| 04/07/2009 | US7514215 Sulfotransferase SULT2A1 sequence variants |
| 04/07/2009 | US7514211 Nucleotide sequences comprising mutation associated with arthritic disorders; allelic variation, disease and gene therapy |
| 04/07/2009 | US7514210 Identifying and characterizing modulators of nucleic acid processing enzymes; enzyme inhibitors |
| 04/07/2009 | US7514209 Diagnosis and prognosis of breast cancer patients |
| 04/07/2009 | US7514208 Methods for identifying modulators of cyclic nucleotide-gated cation channels |
| 04/07/2009 | US7514110 Talaromyces xylanases |
| 04/07/2009 | US7514098 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 04/07/2009 | US7514089 Mutant Salmonella species with genetically engineered MSBB gene, expresses altered lipid, has reduced inductino of tumor necrosis factor and increased sensitivity to chelating agents; as antitumor agent |
| 04/07/2009 | US7514087 Administering primer and boosting composition comprising source of one or more CD8+ T cell epitopes of melanoma from a source of non-replicating or replication-deficient recombinant poxvirus vector in the human |
| 04/07/2009 | US7514084 isolated nonapeptide that bind to an human leukocyte antigen (HLA-A 0201) restricted T cell receptors with high affinity and induce a high cytotoxic T lymphocyte response, used for treating or preventing tumors and cancers |
| 04/07/2009 | US7514078 Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| 04/07/2009 | US7514073 Reduced vasopermeability activity and similar binding affinity for an IL-2 receptor compared to its wildtype form; immunostimulants; immuotherapy; anticarcinogenic agents; renal cell cancer, melanoma; chemotherapy and/or radiation therapy; viricides; human immunodeficiency virus; autoimmune disorders |
| 04/07/2009 | CA2453382C Mannitol and glucitol derivatives |
| 04/07/2009 | CA2413190C Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 04/07/2009 | CA2411649C Ires enabled gene trapping in plants |
| 04/07/2009 | CA2396113C Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 04/07/2009 | CA2389943C Human antibodies that bind human tnf.alpha. |
| 04/07/2009 | CA2387440C Regulatory region of a lipid transfer protein (ltpw1) from aleurone tissue of wheat |
| 04/07/2009 | CA2313704C Recombinant nodavirus compositions and methods |
| 04/07/2009 | CA2311643C Compositions and methods for inducing gene expression |
| 04/07/2009 | CA2297254C A transformed brassica cc genome |
| 04/07/2009 | CA2294575C Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
| 04/07/2009 | CA2290883C Method for enhancement of naturally occurring cytoplasmic male sterility and for restoration of male fertility and uses thereof in hybrid crop production |
| 04/07/2009 | CA2269060C Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/07/2009 | CA2268386C High molecular weight trichoderma cellulase |
| 04/07/2009 | CA2265801C Method and apparatus for analyzing images |
| 04/07/2009 | CA2264488C A method for generating birnavirus from synthetic rna transcripts |
| 04/07/2009 | CA2242398C Nucleic acid molecules from plants coding enzymes which participate in the starch synthesis |
| 04/07/2009 | CA2234118C Improved immortalized human skin cell lines and novel serum-free medium useful for the production thereof |
| 04/07/2009 | CA2220447C Novel fusion protein recovery and purification methods |
| 04/07/2009 | CA2210871C Human dnase i variants |
| 04/07/2009 | CA2208519C Viral vector complexes having adapters of predefined valence |
| 04/07/2009 | CA2207608C Isolation of nucleic acid |
| 04/07/2009 | CA2206343C Reagents and processes for targeting mutant epidermal growth factor receptors |
| 04/07/2009 | CA2205914C Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells |
| 04/07/2009 | CA2175332C Haemophilus transferrin receptor genes |
| 04/07/2009 | CA2151883C Synthetic tropoelastin |
| 04/07/2009 | CA2136350C Xylanases from trichoderma reesei and methods for their production |
| 04/07/2009 | CA2127262C Somatostatin receptors |
| 04/07/2009 | CA2100472C Inherited and somatic mutations of apc gene in colerectal cancer of humans |
| 04/02/2009 | WO2009042910A2 Ship inhibition to direct hematopoietic stem cells and induce extramedullary hematopoiesis |
| 04/02/2009 | WO2009042871A1 Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same |
| 04/02/2009 | WO2009042846A1 Polypeptides having acetylxylan esterase activity and polynucleotides encoding same |
| 04/02/2009 | WO2009042794A2 Venezuelan equine encephalitis replicons expressing paramyxovirus glycoproteins as vaccine |
| 04/02/2009 | WO2009042753A1 Bs3 resistance gene and methods of use |
| 04/02/2009 | WO2009042734A2 Radiation-resistant mutants of a halophilic archaeon and uses thereof |
| 04/02/2009 | WO2009042723A1 Transgenic mice expressing hypersensitive nicotinic receptors |
| 04/02/2009 | WO2009042501A1 Apparatus for performing electrodistention on algae cells |
| 04/02/2009 | WO2009042488A2 Advanced cervical cell screening methods |
| 04/02/2009 | WO2009042457A1 Nucleic acid isolation in preserved whole blood |
| 04/02/2009 | WO2009042164A1 Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genes |
| 04/02/2009 | WO2009042162A2 Compositions and methods for inhibiting interleukin pathways |
| 04/02/2009 | WO2009042115A2 Methods of designing short hairpin rnas (shrnas) for gene silencing |
| 04/02/2009 | WO2009042070A2 Production of isoprenoids |
| 04/02/2009 | WO2009041858A1 METHOD FOR PRODUCING HUMAN PROINSULIN RECOMBINANT c-PEPTIDE |
| 04/02/2009 | WO2009041760A1 Screening method for the composition for prevention or treatment of osteoporosis and metabolic bone disease using tallyho/jngj mouse |